Table 1.
Author | Age group | Dose | n | Outcome | Result in scGOS/lcFOS group |
Costalos 2008 | Term | 0.4 g/100 mL | 140 (2 groups) | Stool frequency | Statistically significant increase after 10 wk of intervention |
Stool consistency | Statistically significant softer stools after 10 wk of intervention | ||||
Moro 2002 | Term | 0.4/0.8 g/100 mL | 90 (3 groups) | Stool frequency | Statistically significant increase after 4 wk of intervention |
Stool consistency | Statistically significant softer stools after 4 wk of intervention | ||||
Veereman 2011 | Term | 0.8 g/100 mL | 76 (5 groups) | Stool frequency | No statistically significant differences |
Stool consistency | Statistically significant softer stools after 2 and 4 wk of intervention | ||||
Bisceglia 2009 | Term | 0.8 g/100 mL | 76 (2 groups) | Stool frequency | Statistically significant increase throughout 4 wk of intervention |
Stool consistency | Not measured | ||||
Boehm 2002 | Preterm | 1.0 g/100 mL | 42 (3 groups) | Stool frequency | Statistically significant increase after 4 wk of intervention |
Stool consistency | Statistically significant softer stools after 4 wk of intervention | ||||
Mihatsch 2006 | Preterm | 1.0 g/100 mL | 20 (2 groups) | Stool frequency | No statistically significant differences |
Stool consistency | Results not provided | ||||
Viscosity | Statistically significant lower viscosity after 2 wk of intervention | ||||
Modi 2010 | Preterm | 0.8 g/100 mL | 150 (2 groups) | Stool frequency | No statistically significant differences |
Stool consistency | No statistically significant differences |
scGOS/lcFOS: Short chain galacto-oligosaccharides and long-chain fructo-oligosaccharides.